⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LSTA News
Lisata Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
LSTA
TARS
ACHV
Lisata Therapeutics Appoints Jeff Farrow to Board of Directors
globenewswire.com
TARS
LSTA
ACHV
Arteriosclerosis Obliterans Market Shows Promising Growth Prospects During the Forecast Period (2026-2036) Amid Evolving Treatment Landscape | DelveInsight
prnewswire.com
LLY
REGN
LSTA
ABT
PFE
JNJ
MRK
BMY
AZN
NVS
AMGN
GILD
BIIB
Lisata Therapeutics Announces New Method of Use Patent Granted for Certepetide in the Treatment of Pancreatic Cancer and Other Solid Tumors
globenewswire.com
LSTA
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly
globenewswire.com
LSTA
Halper Sadeh LLC is Investigating Whether BWIN, LSTA, ACVA are Obtaining Fair Deals for their Shareholders
globenewswire.com
BWIN
LSTA
ACVA
EQUITY ALERT - The M&A Class Action Firm Launches Inquiry -- LSTA, FSHP, BWIN, and ACVA
prnewswire.com
LSTA
FSHP
BWIN
ACVA
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026
globenewswire.com
LSTA
Chronic Kidney Disease (CKD) Market Gains Momentum as Pipeline Innovation and Clinical Trials Reshape the Competitive Landscape in 2026
globenewswire.com
AZN
LLY
REGN
IONS
MRK
XRTX
DMAC
LSTA
Form 8-K
sec.gov
LSTA